Cantor raises PFE, LLY, MRK price targets, flags Pfizer growth concerns
Cantor Fitzgerald lifted price targets on Pfizer, Eli Lilly and Merck, citing upcoming trial results and earnings expectations, while flagging growth concerns for Pfizer.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Cantor Fitzgerald lifted price targets on Pfizer, Eli Lilly and Merck, citing upcoming trial results and earnings expectations, while flagging growth concerns for Pfizer.